AaronHWolfsonMDFACR

Clinical Trials

• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus Start of enrollment: 1993 Dec 01

  Completed

  Phase 3

• Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer Start of enrollment: 2003 Feb 01

  Completed

  Phase 2

• Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery Start of enrollment: 2002 May 01

  Completed

  Phase 1

• Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Start of enrollment: 2004 Mar 01

  Completed

  Phase 1

• Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12

  Active, not recruiting

  Phase 3

• MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer Start of enrollment: 2011 Dec 27

  Completed

  Not Applicable

• Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial Start of enrollment: 2011 Oct 31

  Completed

  Not Applicable

• MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial Start of enrollment: 2012 Jul 12

  Active, not recruiting

  Not Applicable

• Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09

  Completed

  Phase 3

• Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer Start of enrollment: 2012 Jan 01

  Completed

  Phase 1

• Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer Start of enrollment: 2011 Oct 13

  Active, not recruiting

  Phase 2, Phase 3

• Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma Start of enrollment: 2013 Jun 03

  Terminated

  Phase 2

• LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma Start of enrollment: 2014 May 01

  Withdrawn

  Phase 1

• Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma Start of enrollment: 2023 Apr 15

  Recruiting

  Phase 1

  Roles: Sponsor-Investigator

• Join now to see all